Add Company
Join Now

Pulmotect Revenue and Competitors

License our Company Data API

Houston, TX USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Pulmotect's estimated annual revenue is currently $1.4M per year.(i)
  • Pulmotect's estimated revenue per employee is $155,000

Employee Data

  • Pulmotect has 9 Employees.(i)
  • Pulmotect grew their employee count by -10% last year.

Pulmotect's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Medical DirectorReveal Email/Phone
4
Project ManagerReveal Email/Phone
5
PresidentReveal Email/Phone
6
Head, Clinical Operations and ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is Pulmotect?

Pulmotect has developed PUL-042, an inhaled therapeutic which aims to boost the body's innate immune system resulting in highly-targeted lung protection against all major classes of pathogens including bacteria, fungi, and viral pathogens. Pulmotect’s initial market focus is on the reduction of chronic obstructive pulmonary disease (COPD) exacerbations, which are characterized by an acute worsening of symptoms mostly precipitated by a bacterial or viral infection.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.2M90%$10.4M
#2
$1.1M9-83%N/A
#3
$0.7M9N/AN/A
#4
$0.7M9N/AN/A
#5
$1.1M9N/AN/A